|Bid||25.64 x 3200|
|Ask||25.65 x 3200|
|Day's Range||25.25 - 26.75|
|52 Week Range||9.85 - 45.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 10, 2021 - Nov. 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||24.76|
Palantir Technologies Inc. (PLTR) closed at $25.52 in the latest trading session, marking a +0.43% move from the prior day.
DENVER, October 26, 2021--Palantir Technologies Inc. (NYSE: PLTR) announced today that results for its third quarter ended September 30, 2021 will be released on Tuesday, November 9, 2021, prior to the open of U.S. markets. Palantir will host a conference call to discuss its results at 6:00 AM MT / 8:00 AM ET.
Abbott Laboratories (NYSE: ABT) and Palantir Technologies (NYSE: PLTR) are two suitable options for long-term investors. Healthcare giant Abbott Laboratories was a great buy before the pandemic and its business looks even better today. The healthcare company is performing incredibly well and is on track to blow past last year's revenue of $34.6 billion as it already has sales of $31.6 billion through the first nine months of 2021.